Literature DB >> 21586193

Prenatal care and adverse pregnancy outcomes among women with depression: a nationwide population-based study.

Chia-Hui Chen1, Herng-Ching Lin.   

Abstract

OBJECTIVE: To evaluate the quantity of prenatal care as a risk factor for giving birth to low birth weight (LBW), preterm, and small for gestational age (SGA) infants in a sample of women diagnosed with depressive disorder.
METHOD: Our study used a population-based dataset, Taiwan's National Health Insurance Research Database, which we linked to Taiwan's birth certificate registry to identify a total of 5283 new mothers with depressive disorder. Multivariate logistic regression analyses were performed to measure the risk of giving birth to LBW, preterm, and SGA infants, relating to the number of prenatal care visits (10 or more, 8 to 9, and 7 or less) made by mothers with depressive disorder.
RESULTS: After adjusting for a woman's age, monthly income, urbanization level of place of residence, geographic location, marital status, substance abuse, arterial hypertension, diabetes, anemia, coronary heart disease, malpresentation, insufficient or excessive fetal growth, placenta or previa abruption, and infant's sex and parity, regression analyses revealed that mothers with a history of depressive disorder who received prenatal care 7 times or less were 4.21 (95% CI 3.34 to 5.32, P < 0.001), 5.37 (95% CI 4.33 to 6.67, P < 0.001), and 2.41 (95% CI 2.03 to 2.86, P < 0.001) times as likely to have LBW, preterm, and SGA babies, respectively, compared with mothers with depressive disorder who received prenatal care visits 10 times or more.
CONCLUSIONS: Mothers with a history of depressive disorder who make fewer prenatal care visits were at an increased risk of LBW, SGA, and preterm birth, compared with women with a history of depressive disorder who made an adequate number of prenatal visits.

Entities:  

Mesh:

Year:  2011        PMID: 21586193     DOI: 10.1177/070674371105600506

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  8 in total

1.  Hypertension: ACE inhibitor use in pregnancy--setting the record straight.

Authors:  Gideon Koren
Journal:  Nat Rev Cardiol       Date:  2011-11-22       Impact factor: 32.419

2.  Disparate patterns of prenatal care utilization stratified by medical and psychosocial risk.

Authors:  Elizabeth E Krans; Matthew M Davis; Christie L Palladino
Journal:  Matern Child Health J       Date:  2013-05

Review 3.  Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.

Authors:  Tamar L Gur; Deborah R Kim; C Neill Epperson
Journal:  Psychopharmacology (Berl)       Date:  2013-05-17       Impact factor: 4.530

Review 4.  Prenatal depression and adverse birth outcomes: an updated systematic review.

Authors:  Eynav Elgavish Accortt; Alyssa C D Cheadle; Christine Dunkel Schetter
Journal:  Matern Child Health J       Date:  2015-06

5.  Elevated risk of adverse obstetric outcomes in pregnant women with depression.

Authors:  Deborah R Kim; Laura E Sockol; Mary D Sammel; Caroline Kelly; Marian Moseley; C Neill Epperson
Journal:  Arch Womens Ment Health       Date:  2013-08-10       Impact factor: 3.633

6.  Relationship between depression and diabetes in pregnancy: A systematic review.

Authors:  Glynis P Ross; Henrik Falhammar; Roger Chen; Helen Barraclough; Ole Kleivenes; Ian Gallen
Journal:  World J Diabetes       Date:  2016-11-15

7.  Association between family functions and antenatal depression symptoms: a cross-sectional study among pregnant women in urban communities of Hengyang city, China.

Authors:  Baohua Zheng; Yunhan Yu; Xidi Zhu; Zhao Hu; Wensu Zhou; Shilin Yin; Huilan Xu
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 2.692

8.  Prevalence of perinatal depression among HIV-positive women: a systematic review and meta-analysis.

Authors:  Qi-Yu Zhu; De-Sheng Huang; Jian-Da Lv; Peng Guan; Xing-Hua Bai
Journal:  BMC Psychiatry       Date:  2019-10-30       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.